Use the buttons below to increase or decrease the text size.
Use the toggle below to switch the contrast.
Listen to the content of the page by clicking play on Read Speaker.
To discover more about accessibility view our Accessibility Options
To : All DHA Licensed Private Hospitals, Outpatient care facilities and pharmaceutical establishments in Dubai
Dubai Health Authority extends its greetings, thanking you all for the continued collaboration wishing you all the best and success.
As part of efforts to combat the existing coved19 pandemicو and based on the adopted evidence based approach, DHA requests all healthcare and pharmaceutical facilities to refrain from using or selling rapid laboratory screening kits to detect blood antibodies to the Covid 19 virus. This method has not yet been proven to be feasible and has not been universally adopted as a reliable diagnostic method. The DHA is continuously on testing the effectiveness of these devices and will inform you in the event of any change in this matter.
Based on the above and in view of the utmost importance, all healthcare professionals and facilities are prohibited from using these tests and all pharmaceutical facilities from selling them either in public sales centers or to health facilities and legal measures will be taken for violators.
With regards, Dubai Health Authority
Rapid Viral Testing- COVID 19.pdf:
You have shared the circular with
Could not share the circular with
Please check if you have entered valid email address
Please be advised that Sheryan doesn't support the current browser. Please use one of the recommended browsers.